These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 10708238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Morphometric effects of long-term exposure to latanoprost.
    Cracknell KP, Grierson I, Hogg P.
    Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Iris morphology.
    Teus MA, Arranz-Marquez E.
    Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients.
    Chiba T, Kashiwagi K, Kogure S, Abe K, Shibuya T, Furuichi M, Iijima H, Tsukahara S.
    J Glaucoma; 2001 Oct; 10(5):406-10. PubMed ID: 11711839
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies.
    Cracknell KP, Grierson I, Hogg P, Appleton P, Pfeiffer N.
    Exp Eye Res; 2003 Dec; 77(6):721-30. PubMed ID: 14609560
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
    Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
    [Abstract] [Full Text] [Related]

  • 18. Increased iris pigment in a child due to latanoprost.
    Brown SM.
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract] [Full Text] [Related]

  • 19. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
    Chou SY, Chou CK, Kuang TM, Hsu WM.
    Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.